43
Growth Score
pts
Heat Score
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Vyera is focused on developing novel treatment options for toxoplasmosis and other rare or serious health conditions.
Nicholas Pelliccione: Sr. Vice President, Head of Research & DevelopmentPast Role: Turing Pharmaceuticals, Vice President, Regulatory Affairs
Ron Tilles: CEO
About the Company
Vyera Pharmaceuticals is focused on developing therapies specifically targeted to treat patients suffering from serious and neglected diseases with high unmet needs. Vyera supports programs that offer financial assistance to patients in need and provides discounts to organizations that provide care to underserved patients.
